| Lantheus Holdings, Inc | $6.5b | $100.84 | 0.0% | 1.1K | |
| Immunome, Inc. | $2.6b | $29.02 | 0.0% | 292 | |
| AbCellera Biologics Inc. Common Shares | $1.7b | $12.17 | 0.0% | 51.0K | |
| Aktis Oncology, Inc. Common stock | $1.2b | $26.35 | 0.0% | 10 | |
| Alpha Tau Medical Ltd. Ordinary Shares | $1.1b | $15.13 | 0.0% | 1.8K | |
| Crescent Biopharma, Inc. Common Stock | $0.5b | $17.97 | 0.0% | 5 | |
| Perspective Therapeutics, Inc. | $331.9m | $3.23 | +3.2% | 331 | |
| PLUS THERAPEUTICS, Inc. Common Stock | $30.1m | $3.91 | 0.0% | N/A | |
| Actinium Pharmaceuticals, Inc | $26.3m | $1.02 | 0.0% | 100 | |
| American Shared Hospital Services | $9.9m | $1.51 | 0.0% | N/A | |
| iTonic Holdings Ltd Class A Ordinary Shares | $4.6m | $0.30 | 0.0% | 11.9K |